Connection
Susan Ingram to Endocannabinoids
This is a "connection" page, showing publications Susan Ingram has written about Endocannabinoids.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.276 |
|
|
|
-
Bouchet CA, McPherson KB, Coutens B, Janowsky A, Ingram SL. Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation. J Neurosci. 2023 07 26; 43(30):5458-5467.
Score: 0.746
-
Coutens B, Bouchet CA, Patti LC, McPherson KB, Boston BS, Jewett DC, Ingram SL. Corticosterone stimulates synthesis of 2-arachidonoylglycerol via putative membrane-bound glucocorticoid receptors and inhibits GABA release via CB1 cannabinoid receptors in the ventrolateral periaqueductal gray. Mol Pharmacol. 2025 08; 107(8):100058.
Score: 0.214
-
Klawitter J, Clauw AD, Seifert JA, Klawitter J, Tompson B, Sempio C, Ingram SL, Christians U, Moreland LW. Endocannabinoid Tone and Oxylipins in Rheumatoid Arthritis and Osteoarthritis-A Novel Target for the Treatment of Pain and Inflammation? Int J Mol Sci. 2025 Jun 14; 26(12).
Score: 0.213
-
Li MH, Suchland KL, Ingram SL. GABAergic transmission and enhanced modulation by opioids and endocannabinoids in adult rat rostral ventromedial medulla. J Physiol. 2015 Jan 01; 593(1):217-30.
Score: 0.103